Applied StemCell
Advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | N/A | Buyout | |
| Total Funding | 000k | ||
Related Content
Applied StemCell, Inc. operates in the biotechnology sector, specializing in CRISPR-based genome editing and stem cell services. The company provides a range of services including the creation of genetically modified cell lines, animal models, and comprehensive preclinical studies. Applied StemCell serves clients in the pharmaceutical, biotechnology, and academic research sectors, focusing on cancer and stem cell research. The company generates revenue through custom service contracts, product sales, and licensing agreements. Their business model is centered around offering high-quality, tailored solutions to accelerate basic research and drug discovery. Key offerings include iPSC differentiation, antibody discovery, and neurotoxicity screening. Applied StemCell's market is global, with a strong emphasis on innovation and precision in genetic engineering.
Keywords: CRISPR, genome editing, stem cells, cancer research, neuroscience, iPSC, antibody discovery, preclinical studies, animal models, biotechnology.